Catalysts for $AZN
72 tracked
Nov 18, 2020
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Nov 10, 2020
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Jun 5, 2020
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Apr 10, 2020
approval
KOSELUGO (SELUMETINIB SULFATE) — FDA approval
selumetinib sulfate
→
Mar 27, 2020
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Nov 21, 2019
approval
CALQUENCE (ACALABRUTINIB) — FDA approval
CALQUENCE
→
Nov 21, 2019
approval
CALQUENCE (ACALABRUTINIB) — FDA approval
CALQUENCE
→
Aug 26, 2019
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Jul 19, 2019
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Feb 16, 2018
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→
Oct 31, 2017
approval
CALQUENCE (ACALABRUTINIB) — FDA approval
CALQUENCE
→
May 1, 2017
approval
IMFINZI (DURVALUMAB) — FDA approval
ASTRAZENECA PLC
→